As the Ebola virus continues to threaten the health situation in Africa particularly in Sierra Leone, scientists are finding out ways to circumvent the spread of the disease and has made new approaches in detecting the virus and providing treatment to those who are infected.
A new study found a way to detect the infection from suspected individuals within minutes, The ReEBOV Antigen Rapid Test; Corgenix, a point-of-care Ebola Virus Disease (EVD) Rapid Diagnostic Test (RDT) shows promising result that and can detect the presence of the Ebola Antigen within minutes, not only that, the Rapid test also seen as sensitive as the conventional laboratory-based molecular procedure used in recent clinical testing.
Earlier, during the outbreak of the infection in Sierra Leone, the ground medical team will have to send patients sample in the Laboratory and could take days for the results to become available. With the newly developed rapid test however, the turn-around-time for the results to come in has been widely shortened that helps identify infected patients immediately and help control the spread of the infection. The only requirements for the test to be done is a small amount of blood and a diagnostic test kit and the result should be visible in minutes.
The rapid test for the EVD could have a major impact in identifying infected patients and could have an immediate impact on patient care and control the spread of infection by reliably detecting patients with infection from those non-infected according to co-author Jana Broadhurst from Partners In Health.
Though the RDT requires refrigeration for storage, the test kits are already available in health centers in infected areas where they have the the storage facilities for other health products that requires the same storage environment.